These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3032877)

  • 1. Multi-modality treatment of primary nonresectable intrahepatic cholangiocarcinoma with 131I anti-CEA--a Radiation Therapy Oncology Group Study.
    Stillwagon GB; Order SE; Klein JL; Leichner PK; Leibel SA; Siegelman SS; Fishman EK; Ettinger DS; Haulk T; Kopher K
    Int J Radiat Oncol Biol Phys; 1987 May; 13(5):687-95. PubMed ID: 3032877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variable low dose rate irradiation (131I-anti-CEA) and integrated low dose chemotherapy in the treatment of nonresectable primary intrahepatic cholangiocarcinoma.
    Stillwagon GB; Order SE; Haulk T; Herpst J; Ettinger DS; Fishman EK; Klein JL; Leichner PK
    Int J Radiat Oncol Biol Phys; 1991 Nov; 21(6):1601-5. PubMed ID: 1657845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iodine 131 antiferritin, a new treatment modality in hepatoma: a Radiation Therapy Oncology Group study.
    Order SE; Stillwagon GB; Klein JL; Leichner PK; Siegelman SS; Fishman EK; Ettinger DS; Haulk T; Kopher K; Finney K
    J Clin Oncol; 1985 Dec; 3(12):1573-82. PubMed ID: 2415692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative tumor dose from 131I-labeled polyclonal anti-ferritin, anti-AFP, and anti-CEA in primary liver cancers.
    Leichner PK; Klein JL; Fishman EK; Siegelman SS; Ettinger DS; Order SE
    Cancer Drug Deliv; 1984; 1(4):321-8. PubMed ID: 6085756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospects of radioimmunotherapy in epithelial ovarian cancer: results with iodine-131-labeled murine and humanized MN-14 anti-carcinoembryonic antigen monoclonal antibodies.
    Juweid M; Swayne LC; Sharkey RM; Dunn R; Rubin AD; Herskovic T; Goldenberg DM
    Gynecol Oncol; 1997 Dec; 67(3):259-71. PubMed ID: 9441773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of radiation dose in combined external beam and intraluminal Ir-192 brachytherapy for bile duct cancer.
    Alden ME; Mohiuddin M
    Int J Radiat Oncol Biol Phys; 1994 Mar; 28(4):945-51. PubMed ID: 8138448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I/II clinical radioimmunotherapy with an iodine-131-labeled anti-carcinoembryonic antigen murine monoclonal antibody IgG.
    Behr TM; Sharkey RM; Juweid ME; Dunn RM; Vagg RC; Ying Z; Zhang CH; Swayne LC; Vardi Y; Siegel JA; Goldenberg DM
    J Nucl Med; 1997 Jun; 38(6):858-70. PubMed ID: 9189130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase-I/II radio-immunotherapy study with Iodine-131-labeled anti-CEA monoclonal antibody F6 F(ab')2 in patients with non-resectable liver metastases from colorectal cancer.
    Ychou M; Pelegrin A; Faurous P; Robert B; Saccavini JC; Guerreau D; Rossi JF; Fabbro M; Buchegger F; Mach JP; Artus JC
    Int J Cancer; 1998 Feb; 75(4):615-9. PubMed ID: 9466665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I/II trial of combined 131I anti-CEA monoclonal antibody and hyperthermia in patients with advanced colorectal adenocarcinoma.
    Mittal BB; Zimmer MA; Sathiaseelan V; Benson AB; Mittal RR; Dutta S; Rosen ST; Spies SM; Mettler JM; Groch MW
    Cancer; 1996 Nov; 78(9):1861-70. PubMed ID: 8909304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 194 hepatocellular cancers treated by radiation and chemotherapy combinations: toxicity and response: a Radiation Therapy Oncology Group Study.
    Stillwagon GB; Order SE; Guse C; Klein JL; Leichner PK; Leibel SA; Fishman EK
    Int J Radiat Oncol Biol Phys; 1989 Dec; 17(6):1223-9. PubMed ID: 2557307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiotherapy of cholangiocarcinoma: the roles for primary and adjuvant therapies.
    Shiina T; Mikuriya S; Uno T; Toita T; Serizawa S; Itami J; Kawai S; Tani M
    Cancer Chemother Pharmacol; 1992; 31 Suppl():S115-8. PubMed ID: 1333898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose-rate remote afterloading intracavitary brachytherapy for the treatment of extrahepatic biliary duct carcinoma.
    Lu JJ; Bains YS; Abdel-Wahab M; Brandon AH; Wolfson AH; Raub WA; Wilkinson CM; Markoe AM
    Cancer J; 2002; 8(1):74-8. PubMed ID: 11895206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in unresectable hepatocellular cancer: Radiation Therapy Oncology Group Study 83-01.
    Stillwagon GB; Order SE; Guse C; Leibel SA; Asbell SO; Klein JL; Leichner PK
    Int J Radiat Oncol Biol Phys; 1991 Jan; 20(1):65-71. PubMed ID: 1847127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I/II study of iodine 131-labeled monoclonal antibody A33 in patients with advanced colon cancer.
    Welt S; Divgi CR; Kemeny N; Finn RD; Scott AM; Graham M; Germain JS; Richards EC; Larson SM; Oettgen HF
    J Clin Oncol; 1994 Aug; 12(8):1561-71. PubMed ID: 8040668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protracted intravenous fluorouracil infusion with radiation therapy in the management of localized pancreaticobiliary carcinoma: a phase I Eastern Cooperative Oncology Group Trial.
    Whittington R; Neuberg D; Tester WJ; Benson AB; Haller DG
    J Clin Oncol; 1995 Jan; 13(1):227-32. PubMed ID: 7799024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOLFIRI plus bevacizumab as a second-line therapy for metastatic intrahepatic cholangiocarcinoma.
    Guion-Dusserre JF; Lorgis V; Vincent J; Bengrine L; Ghiringhelli F
    World J Gastroenterol; 2015 Feb; 21(7):2096-101. PubMed ID: 25717243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined external beam radiotherapy and intraluminal high dose rate brachytherapy on bile duct carcinomas.
    Fritz P; Brambs HJ; Schraube P; Freund U; Berns C; Wannenmacher M
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):855-61. PubMed ID: 8040034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients.
    Zeng ZC; Tang ZY; Fan J; Zhou J; Qin LX; Ye SL; Sun HC; Wang BL; Li D; Wang JH; Zeng MS; Guo W; Tan YS
    Cancer J; 2006; 12(2):113-22. PubMed ID: 16630402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo.
    Pederson LC; Buchsbaum DJ; Vickers SM; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA
    Cancer Res; 1997 Oct; 57(19):4325-32. PubMed ID: 9331094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.